---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-22-004019"
form_type: "8-K"
ticker: "CMPX"
cik: "0001738021"
company_name: "Compass Therapeutics, Inc."
filed_at: "2022-05-31T23:59:59+00:00"
generated_at: "2026-06-25T05:57:45.529446+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Compass Therapeutics stockholders elect directors and ratify auditor at 2022 annual meeting

## Summary
- Philip J. Ferneau re-elected with 57.0M votes for, 8.5M withheld; Carl L. Gordon with 55.5M for, 10.0M withheld.
- Ratification of CohnReznick LLP as auditor for FY 2022 passed with 82.3M for, 65,654 against, 5,702 abstain.
- No other proposals or material changes disclosed at the meeting.

## SEC filing metadata
- accession: 0001171843-22-004019
- form_type: 8-K
- ticker: CMPX
- cik: 0001738021
- company_name: Compass Therapeutics, Inc.
- filed_at: 2022-05-31T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1738021/000117184322004019/0001171843-22-004019-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1738021/000117184322004019/f8k_053122.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-22-004019
- JSON: https://secwatch.observer/filing/0001171843-22-004019.json
- Plain text: https://secwatch.observer/filing/0001171843-22-004019.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.